NAPLEX Cardiovascular Pharmacology Practice Questions with Answers

Concept Explanation

NAPLEX cardiovascular pharmacology is the study of drug classes, mechanisms of action, clinical indications, and safety monitoring parameters for medications used to manage heart disease, hypertension, and lipid disorders. Mastering this area requires a deep understanding of how agents like ACE inhibitors, beta-blockers, statins, and antiarrhythmics interact with physiological systems to improve patient outcomes. For comprehensive study strategies, students should refer to our NAPLEX Prep resource to organize their review of these high-yield topics.

Cardiovascular pharmacotherapy often involves balancing efficacy with potential adverse effects. For instance, clinicians must monitor serum creatinine and potassium when initiating renin-angiotensin-aldosterone system (RAAS) inhibitors. Similarly, the American College of Cardiology provides clinical guidelines that dictate the standard of care for conditions like heart failure and ischemic heart disease. Understanding these guidelines, alongside common dosage calculations such as those found in hard NAPLEX dosage calculation practice questions, is essential for board success.

Solved Examples

1. Question: A patient is started on lisinopril 10 mg daily. Which laboratory parameter should be monitored within 1-2 weeks of initiation?
   Solution: ACE inhibitors like lisinopril can cause a decrease in glomerular filtration rate and an increase in serum potassium. Therefore, serum creatinine and potassium must be monitored.
2. Question: A patient with HFrEF is taking carvedilol 6.25 mg BID. What is the target dose for carvedilol in patients weighing less than 85 kg?
   Solution: The target dose for carvedilol (Coreg) in HFrEF for patients < 85 kg is 25 mg BID. For patients > 85 kg, the target is 50 mg BID.
3. Question: A patient on amiodarone presents with yellowing of the skin and eyes. Which organ system is likely affected?
   Solution: Amiodarone is associated with hepatotoxicity. Yellowing (jaundice) indicates an adverse effect on the liver, necessitating immediate monitoring of liver function tests (LFTs).

Practice Questions

1. Which of the following statins is considered a high-intensity statin at a dose of 40 mg daily?
2. A patient is prescribed spironolactone for heart failure. Which side effect is most likely to occur?
3. Which antiarrhythmic agent is classified as a Class III agent and requires baseline pulmonary function tests?

4. What is the primary mechanism of action of sacubitril/valsartan?
5. Which calcium channel blocker is preferred in a patient with HFrEF?
6. A patient on warfarin has an INR of 5.5. What is the recommended management according to clinical guidelines?
7. Which medication class is generally avoided in patients with a history of angioedema?
8. What is the maximum daily dose of simvastatin when taken with amiodarone?
9. Which diuretic is most associated with ototoxicity?
10. Explain the rationale for using beta-blockers in patients post-myocardial infarction.

Answers & Explanations

1. Atorvastatin 40 mg. High-intensity statins include Atorvastatin 40-80 mg and Rosuvastatin 20-40 mg.
2. Gynecomastia. Spironolactone is a non-selective aldosterone antagonist that can cause anti-androgenic effects.
3. Amiodarone. It has a high risk of pulmonary toxicity; baseline and annual PFTs are recommended.
4. Neprilysin inhibition and ARB. Sacubitril inhibits neprilysin, while valsartan blocks the angiotensin II receptor.
5. None. Non-dihydropyridine CCBs are generally contraindicated in HFrEF due to negative inotropic effects.
6. Hold warfarin and consider low-dose Vitamin K. Per ACC/AHA guidelines, if INR is > 4.5 but < 10 without bleeding, hold warfarin and monitor.
7. ACE Inhibitors. These drugs increase bradykinin, which is linked to the development of angioedema.
8. 20 mg. Simvastatin has a dose limit of 20 mg when used with amiodarone to reduce the risk of myopathy.
9. Furosemide. Loop diuretics have a dose-dependent risk of ototoxicity, especially when administered rapidly via IV.
10. Reduction of myocardial oxygen demand. Beta-blockers decrease heart rate and contractility, reducing the workload on the heart.

Quick Quiz

Frequently Asked Questions

Why are ACE inhibitors contraindicated in pregnancy?

ACE inhibitors are associated with fetal renal failure and malformations. They are classified as Category X during pregnancy due to these significant risks.

How do non-dihydropyridine CCBs differ from dihydropyridines?

Non-dihydropyridines (diltiazem, verapamil) have significant negative inotropic and chronotropic effects on the heart. Dihydropyridines (amlodipine, nifedipine) primarily act as potent peripheral vasodilators.

What is the clinical significance of the CHADS2-VASc score?

The CHADS2-VASc score is used to assess the risk of stroke in patients with atrial fibrillation. It helps determine the necessity of long-term anticoagulation therapy.

Why is baseline monitoring important for amiodarone?

Amiodarone has a long half-life and affects multiple organ systems, including the thyroid, lungs, and liver. Baseline and ongoing monitoring are critical for patient safety.

What is the role of Ezetimibe in lipid management?

Ezetimibe inhibits cholesterol absorption in the small intestine. It is often used as an add-on therapy to statins in patients who do not reach LDL goals.

Tags

Enjoyed this article?

Share it with others who might find it helpful.

Share Article